Documentation scienceplus.abes.fr version Bêta

À propos de : New Japanese Rubella Vaccine: Comparative Trials        

AttributsValeurs
type
Is Part Of
Subject
Title
  • New Japanese Rubella Vaccine: Comparative Trials
has manifestation of work
related by
Abstract
  • A total of 142 seronegative volunteers were given one of the following rubella vaccines: Cendehill, HPV77. DE-5, RA27/3, or a new Japanese vaccine, To-336. To-336 vaccine produced a slightly higher geometric mean antibody titre (G.M.T.) (65·7) than did the HPV77. DE-5 (63·1) or RA27/3 vaccine (61·9) but the G.M.T. induced by Cendehill vaccine was much lower (39·3). Reactions, particularly joint symptoms, occurred least commonly after vaccination with To-336 vaccine. Joint symptoms occurred within seven days of menstruation in 30 out of 37 (81%) vaccines (P <0·01); their incidence was not related to oral contraception. Though there is evidence to suggest that Japanese virus strains may be non-teratogenic further data on the incidence of congenitally acquired infection in Japan must be collected before this conclusion can be supported on epidemiological grounds.
article type
is part of this journal
PubMed ID
  • 4602899



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata